
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
So‐Yeon Park, Jang‐Hyun Choi, Jeong‐Seok Nam
Cancers (2019) Vol. 11, Iss. 7, pp. 965-965
Open Access | Times Cited: 150
So‐Yeon Park, Jang‐Hyun Choi, Jeong‐Seok Nam
Cancers (2019) Vol. 11, Iss. 7, pp. 965-965
Open Access | Times Cited: 150
Showing 1-25 of 150 citing articles:
Advances in immunotherapy for triple-negative breast cancer
Yang Liu, Yueting Hu, Jinqi Xue, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 123
Yang Liu, Yueting Hu, Jinqi Xue, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 123
Tissue mechanics in stem cell fate, development, and cancer
Mary-Kate Hayward, Jonathon M. Muncie, Valerie M. Weaver
Developmental Cell (2021) Vol. 56, Iss. 13, pp. 1833-1847
Open Access | Times Cited: 115
Mary-Kate Hayward, Jonathon M. Muncie, Valerie M. Weaver
Developmental Cell (2021) Vol. 56, Iss. 13, pp. 1833-1847
Open Access | Times Cited: 115
Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
Xiangyi Kong, Yihang Qi, Xiangyu Wang, et al.
Progress in Materials Science (2023) Vol. 134, pp. 101070-101070
Closed Access | Times Cited: 86
Xiangyi Kong, Yihang Qi, Xiangyu Wang, et al.
Progress in Materials Science (2023) Vol. 134, pp. 101070-101070
Closed Access | Times Cited: 86
Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Huangcan Li, Zhuoying Feng, Ming‐Liang He
Theranostics (2020) Vol. 10, Iss. 16, pp. 7053-7069
Open Access | Times Cited: 118
Huangcan Li, Zhuoying Feng, Ming‐Liang He
Theranostics (2020) Vol. 10, Iss. 16, pp. 7053-7069
Open Access | Times Cited: 118
Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond
Xiaoli Zhang, Kimerly Powell, Lang Li
Cancers (2020) Vol. 12, Iss. 12, pp. 3765-3765
Open Access | Times Cited: 101
Xiaoli Zhang, Kimerly Powell, Lang Li
Cancers (2020) Vol. 12, Iss. 12, pp. 3765-3765
Open Access | Times Cited: 101
Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
Stefania Cocco, Michela Piezzo, Alessandra Calabrese, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4579-4579
Open Access | Times Cited: 96
Stefania Cocco, Michela Piezzo, Alessandra Calabrese, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4579-4579
Open Access | Times Cited: 96
Signaling pathways governing breast cancer stem cells behavior
Kai Song, Maryam Farzaneh
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 92
Kai Song, Maryam Farzaneh
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 92
Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling
Ngoc Bao To, Yen Nguyen, Jeong Yong Moon, et al.
Nutrients (2020) Vol. 12, Iss. 6, pp. 1663-1663
Open Access | Times Cited: 84
Ngoc Bao To, Yen Nguyen, Jeong Yong Moon, et al.
Nutrients (2020) Vol. 12, Iss. 6, pp. 1663-1663
Open Access | Times Cited: 84
An Insight Into the Cancer Stem Cell Survival Pathways Involved in Chemoresistance in Triple-Negative Breast Cancer
Hina Qayoom, Nissar Ahmad Wani, Bader Alshehri, et al.
Future Oncology (2021) Vol. 17, Iss. 31, pp. 4185-4206
Closed Access | Times Cited: 81
Hina Qayoom, Nissar Ahmad Wani, Bader Alshehri, et al.
Future Oncology (2021) Vol. 17, Iss. 31, pp. 4185-4206
Closed Access | Times Cited: 81
Targeting Autophagy in Breast Cancer
Stefania Cocco, Alessandra Leone, Michela Piezzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7836-7836
Open Access | Times Cited: 78
Stefania Cocco, Alessandra Leone, Michela Piezzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7836-7836
Open Access | Times Cited: 78
TNF-α increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-κB pathway
Wenjing Liu, Xiaoqing Lu, Peiguo Shi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 76
Wenjing Liu, Xiaoqing Lu, Peiguo Shi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 76
Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
Saikat Ghosh, Ankit Javia, Saritha Shetty, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 27-58
Closed Access | Times Cited: 66
Saikat Ghosh, Ankit Javia, Saritha Shetty, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 27-58
Closed Access | Times Cited: 66
Regulation of cancer stem cells in triple negative breast cancer
Norman Fultang, Madhuparna Chakraborty, Bela Peethambaran
Cancer Drug Resistance (2021)
Open Access | Times Cited: 63
Norman Fultang, Madhuparna Chakraborty, Bela Peethambaran
Cancer Drug Resistance (2021)
Open Access | Times Cited: 63
Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity
Rui Zhang, Juchuanli Tu, Suling Liu
Seminars in Cancer Biology (2021) Vol. 82, pp. 11-25
Open Access | Times Cited: 62
Rui Zhang, Juchuanli Tu, Suling Liu
Seminars in Cancer Biology (2021) Vol. 82, pp. 11-25
Open Access | Times Cited: 62
Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models
Stefania Cocco, Alessandra Leone, Maria Serena Roca, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 55
Stefania Cocco, Alessandra Leone, Maria Serena Roca, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 55
Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells
Jessica E. Pullan, Kaitlin M. Dailey, Sangeeta Bhallamudi, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 5, pp. 2163-2175
Open Access | Times Cited: 43
Jessica E. Pullan, Kaitlin M. Dailey, Sangeeta Bhallamudi, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 5, pp. 2163-2175
Open Access | Times Cited: 43
Biodegradable cascade nanocatalysts enable tumor-microenvironment remodeling for controllable CO release and targeted/synergistic cancer nanotherapy
Jianrong Wu, Zheying Meng, Agata A. Exner, et al.
Biomaterials (2021) Vol. 276, pp. 121001-121001
Closed Access | Times Cited: 53
Jianrong Wu, Zheying Meng, Agata A. Exner, et al.
Biomaterials (2021) Vol. 276, pp. 121001-121001
Closed Access | Times Cited: 53
Cellular Plasticity in Breast Cancer Progression and Therapy
Deguang Kong, Connor J. Hughes, Heide L. Ford
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 52
Deguang Kong, Connor J. Hughes, Heide L. Ford
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 52
Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
Yan Lv, Xiao Ma, Yuxin Du, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 589-607
Open Access | Times Cited: 50
Yan Lv, Xiao Ma, Yuxin Du, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 589-607
Open Access | Times Cited: 50
The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
Lin He, Neda Wick, Sharon Koorse Germans, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6209-6209
Open Access | Times Cited: 45
Lin He, Neda Wick, Sharon Koorse Germans, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6209-6209
Open Access | Times Cited: 45
THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer
Xupeng Bai, Jie Ni, Julia Beretov, et al.
Advanced Science (2021) Vol. 8, Iss. 24
Open Access | Times Cited: 41
Xupeng Bai, Jie Ni, Julia Beretov, et al.
Advanced Science (2021) Vol. 8, Iss. 24
Open Access | Times Cited: 41
Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer
Taylor P Berke, Simon H. Slight, Salman M. Hyder
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 23-30
Open Access | Times Cited: 34
Taylor P Berke, Simon H. Slight, Salman M. Hyder
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 23-30
Open Access | Times Cited: 34
Autophagy inhibits cancer stemness in triple‐negative breast cancer via miR‐181a‐mediated regulation of ATG5 and/or ATG2B
Jee Won Park, Yesol Kim, Soo-Been Lee, et al.
Molecular Oncology (2022) Vol. 16, Iss. 9, pp. 1857-1875
Open Access | Times Cited: 33
Jee Won Park, Yesol Kim, Soo-Been Lee, et al.
Molecular Oncology (2022) Vol. 16, Iss. 9, pp. 1857-1875
Open Access | Times Cited: 33
Piperlongumine loaded PLGA nanoparticles inhibit cancer stem-like cells through modulation of STAT3 in mammosphere model of triple negative breast cancer
Priya Singh, Sanjeeb Kumar Sahoo
International Journal of Pharmaceutics (2022) Vol. 616, pp. 121526-121526
Closed Access | Times Cited: 29
Priya Singh, Sanjeeb Kumar Sahoo
International Journal of Pharmaceutics (2022) Vol. 616, pp. 121526-121526
Closed Access | Times Cited: 29
Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression
Nami Yamashita, Donald Küfe
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8219-8219
Open Access | Times Cited: 29
Nami Yamashita, Donald Küfe
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8219-8219
Open Access | Times Cited: 29